Josh Hexter works as a corporate venture investor at Oramed Pharmaceuticals. The firm's known portfolio counts 2 companies.
Is Josh Hexter a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Late-Stage
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Affiliated at Oramed Pharmaceuticals, whose known portfolio counts 2 companies
- Alpha Tau Medical
- Lifeward
Investor Profile
Josh Hexter is listed against sector Healthcare, and focus areas Biotech, MedTech, Medical Devices and Pharma in the database.
Oramed Pharmaceuticals appears in Late-Stage rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Josh Hexter matches their raise.
Frequently asked questions
Who is Josh Hexter?
Josh Hexter is a corporate venture investor based in Israel, listed at Oramed Pharmaceuticals. The known portfolio of that firm counts 2 companies. That portfolio belongs to the firm, not to Josh Hexter personally.
What does Josh Hexter invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, MedTech, Medical Devices and Pharma. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Josh Hexter invest at?
Oramed Pharmaceuticals appears in Late-Stage rounds across its known deals, and Josh Hexter is listed there. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Josh Hexter listed at?
Josh Hexter is listed at Oramed Pharmaceuticals, whose known portfolio counts 2 companies.
How do I contact Josh Hexter?
An email address, a phone number and a LinkedIn page are on file for Josh Hexter. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal